Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC) Sees Significant Decrease in Short Interest

→ Next-Gen AI is Creating Millionaires Right Now (From InvestorPlace) (Ad)

Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC - Get Free Report) was the target of a large drop in short interest in the month of May. As of May 15th, there was short interest totalling 100 shares, a drop of 92.3% from the April 30th total of 1,300 shares. Based on an average daily trading volume, of 22,600 shares, the days-to-cover ratio is presently 0.0 days.

Get BLAC alerts:

Hedge Funds Weigh In On Bellevue Life Sciences Acquisition

Institutional investors and hedge funds have recently modified their holdings of the business. Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its stake in Bellevue Life Sciences Acquisition by 82.8% in the third quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 220,723 shares of the company's stock valued at $2,296,000 after buying an additional 100,000 shares in the last quarter. Wolverine Asset Management LLC lifted its position in Bellevue Life Sciences Acquisition by 40.6% in the 3rd quarter. Wolverine Asset Management LLC now owns 173,110 shares of the company's stock valued at $1,800,000 after acquiring an additional 50,000 shares in the last quarter. Robinson Capital Management LLC acquired a new position in Bellevue Life Sciences Acquisition in the 3rd quarter worth $438,000. AQR Arbitrage LLC increased its holdings in Bellevue Life Sciences Acquisition by 349.7% during the 3rd quarter. AQR Arbitrage LLC now owns 449,702 shares of the company's stock worth $4,677,000 after purchasing an additional 349,702 shares in the last quarter. Finally, Wealthspring Capital LLC raised its stake in shares of Bellevue Life Sciences Acquisition by 335.7% in the 4th quarter. Wealthspring Capital LLC now owns 87,579 shares of the company's stock valued at $920,000 after purchasing an additional 67,479 shares during the period. 55.30% of the stock is currently owned by institutional investors and hedge funds.

Bellevue Life Sciences Acquisition Stock Performance

NASDAQ:BLAC remained flat at $10.73 on Tuesday. The company's stock had a trading volume of 14 shares, compared to its average volume of 7,196. Bellevue Life Sciences Acquisition has a 1 year low of $10.18 and a 1 year high of $11.60. The stock's fifty day moving average price is $10.72 and its 200-day moving average price is $10.60.

About Bellevue Life Sciences Acquisition

(Get Free Report)

Bellevue Life Sciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in Bellevue, Washington.

Should you invest $1,000 in Bellevue Life Sciences Acquisition right now?

Before you consider Bellevue Life Sciences Acquisition, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bellevue Life Sciences Acquisition wasn't on the list.

While Bellevue Life Sciences Acquisition currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here